REFERENCES
- Tabulation of reports prepared by the Panel on Hematology of the Registry of Adverse Drug Reactions. Council on Drugs, American Medical Association, May 1965, Jun 1967
- Knospe WH, Crosby WH: Aplastic anemia: A disorder of the bone-marrow sinusoidal microcirculation rather than stem-cell failure? Lancet 1:20, 1971
- Scott JL, Finegold SM, Belkin GA, et al: A controlled double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med 272:1137, 1965
- Weisberger AS, Wolfe S, Armentrout S: Inhibition of protein synthesis in mammalian cell free system by chloramphenicol. J Exp Med 120:161, 1964
- Yunis AA, Bloomberg GR: Chloramphenicol toxicity: Clinical features and pathogenesis. Prog Hematol 4:138, 1964
- Yunis AA, Smith US, Restropo A: Reversible bone marrow suppression from chloramphenicol. Arch Intern Med 126:272, 1970
- Yunis AA, Harrington WJ: Patterns of inhibition by chloramphenicol of nucleic acid synthesis in human bone marrow and leukemic cells. J Lab Clin Med 56:831, 1960
- Worlledge SM, Carstairs KC, Dacie JV: Autoimmune hemolytic anemia associated with alpha-methyldopa therapy. Lancet 2:135, 1966
- Swanson MA, Chahmougan D, Schwartz RS: Immunohemolytic anemia due to antipenicillin antibodies. N Engl J Med 274:178, 1966
- Molthan L, Reidenberg NM, Eichman MF: Positive direct Coombs tests due to cephalothin. N Engl J Med 277:123, 1967
- Harris JW: Studies on the mechanism of drug- induced hemolytic anemia. J Lab Clin Med 47:760, 1956
- Beutler E: The hemolytic effect of primaquine and related compounds? A review. Blood 14:103, 1959
- Hoffbrand AV, Necheles TF: Mechanism of folate deficiency in patients receiving phenytoin. Lancet 2:528, 1968
- Streiff RR: Malabsorption of polyglutamic folic acid secondary to oral contraceptives. Clin Res 17:345, 1969
- Pisciotta AV: Drug induced leukopenia and aplastic anemia. Clin Pharmacol Ther 12:13, 1971
- Madison FW, Squier TL: The etiology of primary granulocytopenia (agranulocytic angina). JAMA 102:755, 1934
- Miescher P: Leucopenies et agranulocytoses d'origine immunologique. Sangre (Bare) 26:71, 1955
- Tullis JL: Prevalence, nature and identification of leukocyte antibodies. N Engl J Med 258:569, 1958
- McIntyre PA, Laleli YR, Hodkinson BA, et al: Evidence for anti-leukocyte antibodies as a mechanism for drug-induced agranulocytosis. Proc Assoc Am Physicians 84:217, 1971
- Moeschlin SJ, Wagner K: Agranulocytosis due to the occurrence of leukocyte agglutinins. Acta Haematol 8:29, 1952
- Pisciotta AV: Agranulocytosis induced by certain phenothiazine derivatives. JAMA 208:1862, 1969
- Mansour M, Broun GO Jr: Depression of erythropoiesis associated with chlorpromazine therapy. Arch Intern Med 11:113, 1967
- Pisciotta AV: Studies on agranulocytosis IX. A biochemical defect in chlorpromazine-sensitive marrow cells. J Lab Clin Med 78:435–748, 1971
- Shulman NR: Mechanism of blood cell damage by absorption of antigen-antibody complexes. In Miescher PA, Grabar PJ (Editors): Immunopathology, IIIrd International Symposium. New York, Gnine & Stratton, Inc, 1963, p 338
- Eisner EV, Shahidi NT: Immune thrombocytopenia due to drug metabolite. N Engl J Med 287:376, 1972